Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis

• Hoofdauteurs: Jiaxin Zhu (Auteur), Tiantian Zhang (Auteur), Jiahao Li (Auteur), Junming Lin (Auteur), Wenhua Liang (Auteur), Wenjie Huang (Auteur), Ning Wan (Auteur), Jie Jiang (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2019-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Programmed cell death 1 (PD-1) or programmed cell death ligand 1 (PD-L1) inhibitions are being strongly recommended for the treatment of various cancers, while the efficacy of PD-1/PD-L1 inhibitions varies from individuals. It is urgent to explore some biomarkers to screen the most appro...